MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1471-2261

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations ; volume:22 ; number:1 ; day:18 ; month:6 ; year:2022 ; pages:1-9 ; date:12.2022
BMC cardiovascular disorders ; 22, Heft 1 (18.6.2022), 1-9, 12.2022

Creator: Lin, Li-rong
Hu, Xue-qun
Lu, Li-hong
Dai, Jia-zhen
Lin, Ning-ning
Wang, Re-hua
Xie, Zhang-xin
Chen, Xue-mei

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12872-022-02714-6

URN: urn:nbn:de:101:1-2022081221162796123906

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:21 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lin, Li-rong
Hu, Xue-qun
Lu, Li-hong
Dai, Jia-zhen
Lin, Ning-ning
Wang, Re-hua
Xie, Zhang-xin
Chen, Xue-mei
SpringerLink (Online service)

Other Objects (12)

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Cardiomyopathy, familial dilated

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Cardiomyopathy, familial dilated

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Cardiomyopathy, familial dilated

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Hochschulschrift

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Cardiomyopathy, familial dilated

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Cardiomyopathy, familial dilated

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Screening mutations in myosin binding protein C3 gene in a cohort of patients with Hypertrophic Cardiomyopathy

Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy

Novel Cardiac Myosin Inhibitor Therapy for Hypertrophic Cardiomyopathy in Adults: A Contemporary Review

Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy

β-Cardiac myosin hypertrophic cardiomyopathy mutations release sequestered heads and increase enzymatic activity

Familial hypertrophic obstructive cardiomyopathy with the GLA E66Q mutation and zebra body

Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition

Hypertrophic cardiomyopathy and the myosin mesa: viewing an old disease in a new light

Cardiomyopathy, familial dilated

Takotsubo cardiomyopathy mimicking an apical hypertrophic cardiomyopathy

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Genetic analysis in hypertrophic cardiomyopathy : missense mutations in the ventricular myosin regulatory light chain gene

Related objects

Reset password